The Nature and Excitation Mechanisms of Acoustic Oscillations in Solar and Stellar Coronal Loops

talk at SOHO15, St. Andrews, Scotland, 6-9 September, 2004, to appear in SOHO15 proceedingstalk at SOHO15, St. Andrews, Scotland, 6-9 September, 2004, to appear in SOHO15 proceedingstalk at SOHO15, St. Andrews, Scotland, 6-9 September, 2004, to appear in SOHO15 proceedingstalk at SOHO15, St. Andrews, Scotland, 6-9 September, 2004, to appear in SOHO15 proceedingsIn the recent work of Nakariakov et al. (2004), it has been shown that the time dependences of density and velocity in a flaring loop contain pronounced quasi-harmonic oscillations associated with the 2nd harmonic of a standing slow magnetoacoustic wave. That model used a symmetric heating function (heat deposition was strictly at the apex). This left outstanding questions: A) is the generation of the 2nd harmonic a consequence of the fact that the heating function was symmetric? B) Would the generation of these oscillations occur if we break symmetry? C) What is the spectrum of these oscillations? Is it consistent with a 2nd spatial harmonic? The present work (and partly Tsiklauri et al. (2004b)) attempts to answer these important outstanding questions. Namely, we investigate the physical nature of these oscillations in greater detail: we study their spectrum (using periodogram technique) and how heat positioning affects the mode excitation. We found that excitation of such oscillations is practically independent of location of the heat deposition in the loop. Because of the change of the background temperature and density, the phase shift between the density and velocity perturbations is not exactly a quarter of the period, it varies along the loop and is time dependent, especially in the case of one footpoint (asymmetric) heating. We also were able to model successfully SUMER oscillations observed in hot coronal loops

The running of the electromagnetic coupling alpha in small-angle Bhabha scattering

A method to determine the running of alpha from a measurement of small-angle Bhabha scattering is proposed and worked out. The method is suited to high statistics experiments at e+e- colliders, which are equipped with luminometers in the appropriate angular region. A new simulation code predicting small-angle Bhabha scattering is also presentedComment: 15 pages, 3 Postscript figure

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

Long noncoding RNAs (lncRNAs) are transcripts longer than 200 nucleotides, located within the intergenic stretches or overlapping antisense transcripts of protein coding genes. LncRNAs are involved in numerous biological roles including imprinting, epigenetic regulation, apoptosis, and cell cycle. To determine whether lncRNAs are associated with clinical features and recurrent mutations in older patients (aged \u3e/=60 y) with cytogenetically normal (CN) acute myeloid leukemia (AML), we evaluated lncRNA expression in 148 untreated older CN-AML cases using a custom microarray platform. An independent set of 71 untreated older patients with CN-AML was used to validate the outcome scores using RNA sequencing. Distinctive lncRNA profiles were found associated with selected mutations, such as internal tandem duplications in the FLT3 gene (FLT3-ITD) and mutations in the NPM1, CEBPA, IDH2, ASXL1, and RUNX1 genes. Using the lncRNAs most associated with event-free survival in a training cohort of 148 older patients with CN-AML, we derived a lncRNA score composed of 48 lncRNAs. Patients with an unfavorable compared with favorable lncRNA score had a lower complete response (CR) rate [P \u3c 0.001, odds ratio = 0.14, 54% vs. 89%], shorter disease-free survival (DFS) [P \u3c 0.001, hazard ratio (HR) = 2.88] and overall survival (OS) (P \u3c 0.001, HR = 2.95). The validation set analyses confirmed these results (CR, P = 0.03; DFS, P = 0.009; OS, P = 0.009). Multivariable analyses for CR, DFS, and OS identified the lncRNA score as an independent marker for outcome. In conclusion, lncRNA expression in AML is closely associated with recurrent mutations. A small subset of lncRNAs is correlated strongly with treatment response and survival

Development of an estimative model for the optimal tack coat dosage based on aggregate gradation of hot mix asphalt pavements

In this work the performance of tack coats on asphalt pavement layers is analysed. Adjustment models based on experimental measurements were implemented, relating surface layer macro-texture and aggregate content larger than 8 mm. The best fits were obtained with a Gompertz model, which follows the expected physical macro-texture changes outside the test range. Shear strength was analysed, through prediction curves of each evaluated tack coat dosage, with an optimum tack coat performance for aggregate contents larger than 8 mm between 45% and 50%, and no relevant influence of the tack coat dosage used.The authors would like to acknowledge the support provided by the Technologic Research Construction Group (GITECO) and the Group of Roads of Santander at Cantabria University for the development of tests and samples. We would also like to thank the company Emilio Bolado S.L. and the Society for the Development of Cantabria Region (SODERCAN) for the material provided, and the DID Research Department from the Austral University of Chile for the support

Derivative corrections to the Born-Infeld action through beta-function calculations in N=2 boundary superspace

We calculate the beta-functions for an open string sigma-model in the presence of a U(1) background. Passing to N=2 boundary superspace, in which the background is fully characterized by a scalar potential, significantly facilitates the calculation. Performing the calculation through three loops yields the equations of motion up to five derivatives on the fieldstrengths, which upon integration gives the bosonic sector of the effective action for a single D-brane in trivial bulk background fields through four derivatives and to all orders in alpha'. Finally, the present calculation shows that demanding ultra-violet finiteness of the non-linear sigma-model can be reformulated as the requirement that the background is a deformed stable holomorphic U(1) bundle.Comment: 25 pages, numerous figure

Epidemiological and clinical characteristics of international travelers with enteric fever and antibiotic resistance profiles of their isolates: A GeoSentinel analysis

Copyright © 2020 American Society for Microbiology. All Rights Reserved. Enteric fever, caused by Salmonella enterica serovar Typhi (S. Typhi) and S. enterica serovar Paratyphi (S. Paratyphi), is a common travel-related illness. Limited data are available on the antimicrobial resistance (AMR) patterns of these serovars among travelers. Records of travelers with a culture-confirmed diagnosis seen during or after travel from January 2007 to December 2018 were obtained from GeoSentinel. Traveler demographics and antimicrobial susceptibility data were analyzed. Isolates were classified as nonsusceptible if intermediate or resistant or as susceptible in accordance with the participating site’s national guidelines. A total of 889 travelers (S. Typhi infections, n = 474; S. Paratyphi infections, n = 414; coinfection, n = 1) were included; 114 (13%) were children of (41%) traveled to visit friends and relatives (VFRs) and acquired the infection in South Asia (71%). Child travelers with S. Typhi infection were most frequently VFRs (77%). The median trip duration was 31 days (interquartile range, 18 to 61 days), and 448 of 691 travelers (65%) had no pretravel consultation. Of 143 S. Typhi and 75 S. Paratyphi isolates for which there were susceptibility data, nonsusceptibility to antibiotics varied (fluoroquinolones, 65% and 56%, respectively; co-trimoxazole, 13% and 0%; macrolides, 8% and 16%). Two S. Typhi isolates (1.5%) from India were nonsusceptible to third-generation cephalosporins. S. Typhi fluoroquinolone nonsusceptibility was highest when infection was acquired in South Asia (70 of 90 isolates; 78%) and sub-Saharan Africa (6 of 10 isolates; 60%). Enteric fever is an important travel-associated illness complicated by AMR. Our data contribute to a better understanding of region-specific AMR, helping to inform empirical treatment options. Prevention measures need to focus on high-risk travelers including VFRs and children

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data

Romidepsin is an epigenetic agent approved for the treatment of patients with cutaneous or peripheral T-cell lymphoma (CTCL and PTCL). Here we report data in all patients treated on the National Cancer Institute 1312 trial, demonstrating long-term disease control and the ability to retreat patients relapsing off-therapy. In all, 84 patients with CTCL and 47 with PTCL were enrolled. Responses occurred early, were clinically meaningful and of very long duration in some cases. Notably, patients with PTCL receiving romidepsin as third-line therapy or later had a comparable response rate (32%) of similar duration as the total population (38%). Eight patients had treatment breaks of 35months to 10years; in four of six patients, re-initiation of treatment led to clear benefit. Safety data show slightly greater haematological and constitutional toxicity in PTCL. cDNA microarray studies show unique individual gene expression profiles, minimal overlap between patients, and both induction and repression of gene expression that reversed within 24h. These data argue against cell death occurring as a result of an epigenetics-mediated gene induction programme. Together this work supports the safety and activity of romidepsin in T-cell lymphoma, but suggests a complex mechanism of action